Studii clinice pentru Migrenă în Ohio
13 studii pentru Migrenă caută participanți în Ohio.
Orașe în Ohio
Text oficial al studiului (în engleză)
Study of EVO756 in Adults With Migraine
- NeuroScience Research Center, Canton
În curs de recrutareFaza 2
Vârste de la 18 la 64 · Toate sexele · Actualizat 2 oct. 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
În curs de recrutareFaza 1
Vârste de la 6 la 11 · Toate sexele · Actualizat 28 sept. 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Cincinnati Children's Hospital Medical Center, Cincinnati
În curs de recrutareFaza 3
Vârste de la 6 la 17 · Toate sexele · Actualizat 28 sept. 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Cincinnati Children's Hospital, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
În curs de recrutareFaza 3
Vârste de la 6 la 17 · Toate sexele · Actualizat 24 sept. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
În curs de recrutareFaza 3
Vârste de la 6 la 17 · Toate sexele · Actualizat 24 sept. 2026 · NCT04649242Responding With Evidence and Access for Childhood Headaches
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Childrens, Columbus
În curs de recrutare
Vârste de la 10 la 17 · Toate sexele · Actualizat 21 sept. 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Ohio State University Wexner Medical Center, Columbus
În curs de recrutareFaza 4
Vârste de la 18 la 70 · Toate sexele · Actualizat 16 sept. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Patient Priority Clinical Sites, LLC /ID# 238485, Cincinnati
- University Of Cincinnati Medical Center /ID# 231199, Cincinnati
- Cincinnati Childrens Hospital Medical Center /ID# 244689, Cincinnati
- și încă 3
În curs de recrutareFaza 3
Vârste de la 6 la 17 · Toate sexele · Actualizat 14 sept. 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Hometown Research, Columbus
- Hometown Research, Milford
- CincyScience, West Chester
În curs de recrutareFaza 3
Vârste de la 18 la 75 · Toate sexele · Actualizat 20 aug. 2026 · NCT07645924BE WELL With Migraine: Brain Education and WELLness With Migraine
- Cincinnati Children's Hospital Medical Center, Cincinnati
În curs de recrutare
Vârste de 18 ani și peste · Toate sexele · Actualizat 12 iun. 2026 · NCT05987592A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Childrens Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center - PIN, Cincinnati
În curs de recrutareFaza 3
Vârste de la 6 la 17 · Toate sexele · Actualizat 12 iun. 2026 · NCT05164172Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #4, Cincinnati
În curs de recrutareFaza 4
Vârste de la 6 la 11 · Toate sexele · Actualizat 27 ian. 2025 · NCT04748601Overlapping Pain Trajectory Study
- Cincinnati Children's Hospital, Cincinnati
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de la 10 la 19 · Toate sexele · Actualizat 22 aug. 2024 · NCT05752396Sursă: ClinicalTrials.gov, date preluate la 3 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.